Candace Benjamin

Dr. Candace Benjamin

orcid
PhD. Chemist leveraging expertise in virus-like particles t...

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MLMichael Andrew Luzuriaga
Michael Andrew Luzuriaga
RWRaymond P. Welch
Raymond P. Welch
MDMadushani Dharmarwardana
Madushani Dharmarwardana
CBCandace Benjamin
Candace Benjamin
SLShaobo Li
Shaobo Li
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

11 May 2019 in Supramolecular Chemistry
Verified
Journal Article
Closed access
MLMichael A. Luzuriaga
Michael A. Luzuriaga
CBCandace Benjamin
Candace Benjamin
MGMichael W. Gaertner
Michael W. Gaertner
HLHamilton Lee
Hamilton Lee
FHFabian C. Herbert
Fabian C. Herbert
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith
Drug delivery using metal-organic frameworks (MOF) has elicited interest in their biocompatibility; however, few studies have been conducted on their stability in common buffers, cell media, and blood proteins. In particular, the use of ZIF-8, a MOF interconnected by Zn and methylimidazole, has been frequently employed. In this study, we tested single crystals of ZIF-8 with common laboratory buffers, cell media, and serum, and noted several issues. Buffers containing phosphate and bicarbonate alter the appearance and composition of ZIF-8; however, these buffers do not appear to cause cargo to leak out even when the ZIF-8 itself is displaced by phosphates. On the other hand, serum dissolves ZIF-8, causing premature cargo release. Our results show that ZIF-8 undergoes surface chemistry changes that may affect the interpretation of cellular uptake and cargo release data. On the other hand, it provides a rational explanation as to how ZIF-8 neatly dissolves in vivo.

21 September 2021 in ACS Nano
Verified
Journal Article
Closed access
MLMichael A. Luzuriaga
Michael A. Luzuriaga
FHFabian C. Herbert
Fabian C. Herbert
OBOlivia R. Brohlin
Olivia R. Brohlin
JGJashkaran Gadhvi
Jashkaran Gadhvi
THThomas Howlett
Thomas Howlett
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

22 September 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ASArezoo Shahrivarkevishahi
Arezoo Shahrivarkevishahi
MLMichael A. Luzuriaga
Michael A. Luzuriaga
FHFabian C. Herbert
Fabian C. Herbert
ATAlisia C. Tumac
Alisia C. Tumac
OBOlivia R. Brohlin
Olivia R. Brohlin
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

28 April 2020 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
FHFabian Castro Herbert
Fabian Castro Herbert
OBOlivia R. Brohlin
Olivia R. Brohlin
TGTyler Galbraith
Tyler Galbraith
CBCandace Benjamin
Candace Benjamin
CRCesar A. Reyes
Cesar A. Reyes
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

5 February 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
HLHamilton Lee
Hamilton Lee
ASArezoo Shahrivarkevishahi
Arezoo Shahrivarkevishahi
JLJenica L. Lumata
Jenica L. Lumata
MLMichael A. Luzuriaga
Michael A. Luzuriaga
LHLaurel M. Hagge
Laurel M. Hagge
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith
Many contrast agents for magnetic resonance imaging are based on gadolinium, however side effects limit their use in some patients. Organic radical contrast agents (ORCAs) are potential alternatives, but are reduced rapidly in physiological conditions and have low relaxivities as single molecule contrast agents. Herein, we use a supramolecular strategy where cucurbit[8]uril binds with nanomolar affinities to ORCAs and protects them against biological reductants to create a stable radical in vivo. We further overcame the weak contrast by conjugating this complex on the surface of a self-assembled biomacromolecule derived from the tobacco mosaic virus.